Boston Scientific Banks On ICDs To Spark Stock Growth; Index Slips In 2005
This article was originally published in The Gray Sheet
Executive Summary
Boston Scientific is counting on Guidant shareholders preferring its takeover offer to J&J's to regain Wall Street enthusiasm in the face of diminishing competitive advantages for Taxus and a 31% stock decline in 2005
You may also be interested in...
NuVasive Boosts Artificial Disc Development, Stock; OTC Index Rises 15%
NuVasive will use profits gained from a series of 510(k)-cleared spinal devices to fuel artificial disc and nucleus replacement development in 2006
NuVasive Boosts Artificial Disc Development, Stock; OTC Index Rises 15%
NuVasive will use profits gained from a series of 510(k)-cleared spinal devices to fuel artificial disc and nucleus replacement development in 2006
Gainsharing Demo Program, Medicare Imaging Cuts Included In Budget Bill
The House and Senate passed a deficit reduction bill that would authorize a gainsharing demonstration program at up to six sites beginning in 2007